Supply

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Non-acute settings with healthcare input and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Semi-acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

Risk assessing transcribing for administration

22 February 2022Various factors affect the risks associated with using transcribing for medicines administration.

Alternatives to transcribing for medicines administration

22 February 2022Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.

Understanding transcribing for medicines administration

22 February 2022Transcribing for medicines administration in healthcare requires assessment and mitigation against identified risks. These risks vary according to setting.

Legal mechanisms to supply and administer medicines to individuals

24 January 2022The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)

Supply and/or administration of Controlled Drugs under a PGD

16 November 2021The legal position on the supply and/or administration of controlled drugs under Patient Group Directions is summarised

Unlicensed medicines and use of PGDs

16 November 2021This page explains why PGDs are not a legal mechanism for the administration or supply of unlicensed medicines.

SPS - Specialist Pharmacy Service

NHS